Herceptin has saved countless women’s lives and earned UCLA’s Dr. Dennis Slamon the Lasker Award
Read more >
A three-drug combination researched by an international team of UCLA-led scientists could prove to be an effective new therapy for people with a specific type of advanced melanoma.
Read more >
UCLA Health is among a select group of health systems in the country certified to administer CAR T-cell therapy outside of clinical trials.
Read more >
A pioneering clinic at UCLA Mattel Children’s Hospital is making a significant impact on the lives of children and their families with rare genetic conditions that predispose them to cancer.
Read more >
Two UCLA-led studies have found that using the drug ribociclib in combination with a common hormone therapy may help both pre- and postmenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.
Read more >
